Legal & General Group’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1K | Buy |
4,245
+648
| +18% | +$2.92K | ﹤0.01% | 3020 |
|
|
2025
Q1 | $16.7K | Hold |
3,597
| – | – | ﹤0.01% | 3010 |
|
|
2024
Q4 | $25K | Sell |
3,597
-12,962
| -78% | -$90K | ﹤0.01% | 2952 |
|
|
2024
Q3 | $87.8K | Buy |
16,559
+756
| +5% | +$4.01K | ﹤0.01% | 2738 |
|
|
2024
Q2 | $59.1K | Hold |
15,803
| – | – | ﹤0.01% | 2774 |
|
|
2024
Q1 | $111K | Sell |
15,803
-4,365
| -22% | -$30.8K | ﹤0.01% | 2728 |
|
|
2023
Q4 | $114K | Sell |
20,168
-14,457
| -42% | -$81.7K | ﹤0.01% | 2753 |
|
|
2023
Q3 | $166K | Buy |
34,625
+6,469
| +23% | +$31K | ﹤0.01% | 2757 |
|
|
2023
Q2 | $193K | Buy |
28,156
+19,937
| +243% | +$137K | ﹤0.01% | 2741 |
|
|
2023
Q1 | $64K | Buy |
8,219
+781
| +11% | +$6.08K | ﹤0.01% | 2837 |
|
|
2022
Q4 | $56.6K | Buy |
7,438
+384
| +5% | +$2.92K | ﹤0.01% | 2932 |
|
|
2022
Q3 | $57K | Buy |
7,054
+130
| +2% | +$1.05K | ﹤0.01% | 2946 |
|
|
2022
Q2 | $67K | Buy |
6,924
+1,931
| +39% | +$18.7K | ﹤0.01% | 2946 |
|
|
2022
Q1 | $70K | Buy |
4,993
+1,676
| +51% | +$23.5K | ﹤0.01% | 2940 |
|
|
2021
Q4 | $68K | Buy |
3,317
+2,235
| +207% | +$45.8K | ﹤0.01% | 2978 |
|
|
2021
Q3 | $24K | Sell |
1,082
-1,918
| -64% | -$42.5K | ﹤0.01% | 3212 |
|
|
2021
Q2 | $69K | Buy |
+3,000
| New | +$69K | ﹤0.01% | 2853 |
|